-
Symbol
-
BVXV
-
Investment type
-
Equity / ADSs
-
Latest Disclosed Shares Owned
-
29,051 shares
-
Security Ownership %
-
4.9%
Shares, Excluding Options vs Price
SABBY MANAGEMENT, LLC ownership in Scinai Immunotherapeutics Ltd. ADSs (BVXV)
03 Jan 2025 - SABBY MANAGEMENT, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 29,051 shares of Scinai Immunotherapeutics Ltd. ADSs (BVXV).
This represents 4.9% ownership of the company.
This is the first filing by SABBY MANAGEMENT, LLC disclosing ownership of Scinai Immunotherapeutics Ltd. ADSs (BVXV).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.